FY2024 EPS Estimate for Ascend Wellness Reduced by Analyst

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Investment analysts at Atb Cap Markets reduced their FY2024 earnings per share (EPS) estimates for shares of Ascend Wellness in a note issued to investors on Tuesday, November 12th. Atb Cap Markets analyst F. Gomes now expects that the company will earn ($0.40) per share for the year, down from their prior forecast of ($0.32). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Atb Cap Markets also issued estimates for Ascend Wellness’ Q4 2024 earnings at ($0.08) EPS, FY2026 earnings at ($0.12) EPS, FY2027 earnings at ($0.11) EPS and FY2028 earnings at ($0.09) EPS.

Ascend Wellness Trading Down 6.8 %

OTC AAWH opened at $0.47 on Friday. The firm’s 50 day moving average price is $0.82 and its two-hundred day moving average price is $0.95. The company has a debt-to-equity ratio of 2.61, a quick ratio of 1.29 and a current ratio of 1.47. Ascend Wellness has a twelve month low of $0.42 and a twelve month high of $1.82. The stock has a market cap of $99.66 million, a price-to-earnings ratio of -1.13 and a beta of 1.69.

Ascend Wellness (OTC:AAWH) last released its earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). Ascend Wellness had a negative return on equity of 72.18% and a negative net margin of 15.47%. The business had revenue of $141.65 million during the quarter, compared to the consensus estimate of $144.13 million.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.